In addition, because GLP-1 inhibits the AGEs-induced RAGE gene expression and ROS generation in T2D [158], it may be hypothesized that semaglutide could reduce ROS production through AGE-RAGE mediation [159]. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.